ao link
Business Reporter
Business Reporter
Business Reporter
Search Business Report
My Account
Remember Login
My Account
Remember Login

MyCondro™, The Chondroitin to Make The Move

Sponsored by Gnosis

MyCondro™ is a fermentation-derived, non-animal chondroitin sulfate that redefines joint health and mobility. Clinically validated at 600 mg, it improves knee function, reduces pain, and lowers inflammation markers. Its low molecular weight and superior absorption enable effective low-dose formulations that are vegan, traceable, and free from animal contaminants.

 

The accompanying infographic highlights these benefits, compares MyCondro™ with animal-derived ingredients, and summarizes key data on efficacy, safety, and supply chain transparency. Ideal for athletes, preventive health consumers, and aging populations, MyCondro™ simplifies product development while delivering reliable, science-backed joint support.

 

Download here

Sponsored by Gnosis
Business Reporter

Winston House, 3rd Floor, Units 306-309, 2-4 Dollis Park, London, N3 1HF

23-29 Hendon Lane, London, N3 1RT

020 8349 4363

© 2025, Lyonsdown Limited. Business Reporter® is a registered trademark of Lyonsdown Ltd. VAT registration number: 830519543